BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6781058)

  • 1. [Prolactinomas and "idiopathic" hyperprolactinemia. Case series].
    Volpe A; Grasso A; Oliva A; Bramanti P; Leggiadro N; Musolino R; Meduri M
    Riv Neurol; 1980; 50(5):350-61. PubMed ID: 6781058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of dynamic pituitary function testing in patients with hyperprolactinemia on diagnosis of pituitary prolactin-secreting adenoma (author's transl)].
    Matsuura K
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 May; 34(5):569-78. PubMed ID: 6806416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin secretion after surgery or bromocriptine treatment of prolactinoma.
    De Leo V; Petraglia F; Sardelli S; Danero S; Genazzani AR; D'Antona N
    Obstet Gynecol; 1987 Jan; 69(1):99-103. PubMed ID: 3099236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of follicle-stimulating hormone (FSH) secretion in FSH-producing pituitary adenoma by bromocriptine.
    Berezin M; Olchovsky D; Pines A; Tadmor R; Lunenfeld B
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1220-3. PubMed ID: 6436289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum prolactin and growth hormone response to thyrotropin-releasing hormone in patients with pituitary adenomas.
    Chang CC; Chen FW; Hsieh HC
    Taiwan Yi Xue Hui Za Zhi; 1989 May; 88(5):443-9. PubMed ID: 2507734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A human pituitary adenoma secreting thyrotropin and prolactin: immunohistochemical, biochemical, and cell culture studies.
    Jaquet P; Hassoun J; Delori P; Gunz G; Grisoli F; Weintraub BD
    J Clin Endocrinol Metab; 1984 Nov; 59(5):817-24. PubMed ID: 6480809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum prolactin response to thyrotropin-releasing hormone and metoclopramide in patients with prolactin-secreting tumors before and after transsphenoidal surgery.
    Barbarino A; De Marinis L; Maira G; Menini E; Anile C
    J Clin Endocrinol Metab; 1978 Nov; 47(5):1148-51. PubMed ID: 122421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of bromocriptine, thyrotropin-releasing hormone, and gonadotropin-releasing hormone on hormone secretion by gonadotropin-secreting pituitary adenomas in vivo and in vitro.
    Lamberts SW; Verleun T; Oosterom R; Hofland L; van Ginkel LA; Loeber JG; van Vroonhoven CC; Stefanko SZ; de Jong FH
    J Clin Endocrinol Metab; 1987 Mar; 64(3):524-30. PubMed ID: 3102540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothalamic-pituitary function following bromocriptine therapy in patients with prolactinomas.
    Badawy SZ; Notman DD; Sunderlin FS; Springer JM; Streeten DH; Omar MM; Marshall LD
    J Reprod Med; 1982 Mar; 27(3):139-45. PubMed ID: 6806469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperprolactinemia: comparison of thyrotropic-releasing hormone and tomography.
    Shangold GA; Kletzky OA; Marrs RP; Mishell DR
    Obstet Gynecol; 1984 Jun; 63(6):771-5. PubMed ID: 6427715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Release of thyrotropin releasing hormone (TRH) from human prolactin-secreting pituitary adenoma cells. Modulation by dopamine].
    Le Dafniet M; Blumberg-Tick J; Yuan Li J; Brandi AM; Bression D; Barret A; Feinstein MC; Peillon F
    C R Acad Sci III; 1988; 306(3):129-34. PubMed ID: 3126991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of thyrotropin-releasing hormone and bromoergocriptine on growth hormone and prolactin secretion in perfused pituitary adenoma tissues of acromegaly.
    Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1251-6. PubMed ID: 122426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of the GnRH-TRH and arginine-GnRH-TRH test in females with hyperprolactinemic galactorrhea].
    Rudolf K; Kunkel S; Rudolf H
    Zentralbl Gynakol; 1987; 109(8):501-9. PubMed ID: 3111128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolatin secreting pituitary adenomas.
    Leavens ME; Samaan NA; Larson DL; Jesse RH; Byers RM
    Int Adv Surg Oncol; 1981; 4():277-310. PubMed ID: 6788711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of prolactin secretion in patients with hypopituitarism and pituitary macroadenomas.
    Arafah BM; Nekl KE; Gold RS; Selman WR
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3507-12. PubMed ID: 8530591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromocriptine treatment of microprolactinomas: evidence of stable prolactin decrease after drug withdrawal.
    Moriondo P; Travaglini P; Nissim M; Conti A; Faglia G
    J Clin Endocrinol Metab; 1985 Apr; 60(4):764-72. PubMed ID: 3919052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long term follow-up of women with surgically treated prolactin-secreting pituitary tumors.
    Schlechte JA; Sherman BM; Chapler FK; VanGilder J
    J Clin Endocrinol Metab; 1986 Jun; 62(6):1296-301. PubMed ID: 3084539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathological hyperprolactinemia suppresses hot flashes in menopausal women.
    Scoccia B; Schneider AB; Marut EL; Scommegna A
    J Clin Endocrinol Metab; 1988 Apr; 66(4):868-71. PubMed ID: 3346363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical course and the effectiveness of conservative treatment of prolactin-secreting pituitary adenoma].
    Sabakhtarashvili MA; VeÄ­nberg EG; Kurashvili RB; Kanchaveli ZSh
    Akush Ginekol (Mosk); 1989 Oct; (10):50-4. PubMed ID: 2618957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [GnRH-TRH and arg-GnRH-TRH test in females with normoprolactinemic galactorrhea].
    Rudolf K; Kunkel S; Rudolf H
    Zentralbl Gynakol; 1987; 109(8):510-6. PubMed ID: 3111129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.